Australia markets closed

Kiora Pharmaceuticals Inc (7EY0.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
3.76650.0000 (0.00%)
As of 09:13PM CEST. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
2,808
-12,514
-13,584
-13,771
-6,862
-
Depreciation & amortisation
46.589
51.798
41.609
45.296
33.399
-
Deferred income taxes
-
90.319
-113.01
-192.603
12.055
-
Stock-based compensation
794.446
754.944
462.45
842.475
723.856
-
Change in working capital
-240.984
-1,822
668.513
-1,036
-321.209
-
Accounts payable
-327.413
-808.016
782.463
-310.665
136.697
-
Other working capital
7,137
-9,557
-10,428
-10,739
-7,337
-
Other non-cash items
1,760
2,003
675.024
-323.698
-903.5
-
Net cash provided by operating activities
7,137
-9,557
-10,428
-10,675
-7,317
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-
-63.865
-20.077
-
Acquisitions, net
-
-
0
-93.155
-224.361
0
Net cash used for investing activities
-
0
6.375
-157.02
-244.438
-
Cash flows from financing activities
Debt repayment
-
-
0
-212.282
0
-
Common stock issued
20,855
6,154
5,378
17,745
5,000
-
Common stock repurchased
-1,107
0
-15.629
0
-
-
Other financing activities
-
-495
-
-1,005
-498.687
-104.411
Net cash used provided by (used for) financing activities
20,701
5,966
8,621
17,583
4,998
-
Net change in cash
27,850
-3,555
-1,886
6,669
-2,591
-
Cash at beginning of period
3,430
6,014
7,900
1,231
3,822
-
Cash at end of period
31,268
2,459
6,014
7,900
1,231
-
Free cash flow
Operating cash flow
7,137
-9,557
-10,428
-10,675
-7,317
-
Capital expenditure
-
-
-
-63.865
-20.077
-
Free cash flow
7,137
-9,557
-10,428
-10,739
-7,337
-